Rachel J Gibson1, Dorothy M K Keefe. 1. Department of Medical Oncology, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia. rachel.gibson@imvs.sa.gov.au
Abstract
BACKGROUND: Diarrhoea and constipation are common toxicities of chemotherapy, and both are poorly understood. They are manifestations of alimentary mucositis, a condition which affects the entire gastrointestinal tract. DISCUSSION: The absolute percentage of patients that have diarrhoea or constipation as a result of their treatment has yet to be fully defined, although general estimates place 10% of patients with advanced cancer as being afflicted. Although there has been some major progress in recent years with understanding the mechanisms of oral and small intestinal mucositis, diarrhoea and constipation have received very little attention. Although diarrhoea is a well-recognised side-effect of both chemotherapy and radiotherapy, very little research has been conducted on the mechanisms behind diarrhoea or its treatment. Much of the information in the published literature is based on clinical observations with very little basic science existing. Constipation is not as well recognised and very little is known about its mechanisms. OBJECTIVES: This review will examine in detail the potentially complex pathogenesis of post-chemotherapy diarrhoea in both animal models and the clinical setting. Furthermore, it will explore what is known about chemotherapy-induced constipation. It will then outline an evidence-based pathway for the investigation and treatment of post-chemotherapy diarrhoea and constipation.
BACKGROUND:Diarrhoea and constipation are common toxicities of chemotherapy, and both are poorly understood. They are manifestations of alimentary mucositis, a condition which affects the entire gastrointestinal tract. DISCUSSION: The absolute percentage of patients that have diarrhoea or constipation as a result of their treatment has yet to be fully defined, although general estimates place 10% of patients with advanced cancer as being afflicted. Although there has been some major progress in recent years with understanding the mechanisms of oral and small intestinal mucositis, diarrhoea and constipation have received very little attention. Although diarrhoea is a well-recognised side-effect of both chemotherapy and radiotherapy, very little research has been conducted on the mechanisms behind diarrhoea or its treatment. Much of the information in the published literature is based on clinical observations with very little basic science existing. Constipation is not as well recognised and very little is known about its mechanisms. OBJECTIVES: This review will examine in detail the potentially complex pathogenesis of post-chemotherapy diarrhoea in both animal models and the clinical setting. Furthermore, it will explore what is known about chemotherapy-induced constipation. It will then outline an evidence-based pathway for the investigation and treatment of post-chemotherapy diarrhoea and constipation.
Authors: D Jenkins; M Balsitis; S Gallivan; M F Dixon; H M Gilmour; N A Shepherd; A Theodossi; G T Williams Journal: J Clin Pathol Date: 1997-02 Impact factor: 3.411
Authors: S Wadler; A B Benson; C Engelking; R Catalano; M Field; S M Kornblau; E Mitchell; J Rubin; P Trotta; E Vokes Journal: J Clin Oncol Date: 1998-09 Impact factor: 44.544
Authors: Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis Journal: Cancer Date: 2004-05-01 Impact factor: 6.860
Authors: Agostina Siniscalchi; Andrea Tendas; Micaela Ales; Stefano Fratoni; Luca Cupelli; Teresa Dentamaro; Laura Scaramucci; Marco Giovannini; Tommaso Caravita; Giuseppe Santeusanio; Pasquale Niscola; Paolo de Fabritiis Journal: Support Care Cancer Date: 2009-01-27 Impact factor: 3.603
Authors: Andreas U Lindner; Alexa J Resler; Steven Carberry; Kasia Oficjalska; Orna Bacon; Chun Seng Lee; Abdurehman Choudhry; John P Burke; Kieran Sheahan; Mattia Cremona; Bryan T Hennessy; Deborah McNamara; Glen Doherty; Elizabeth J Ryan; Jochen H M Prehn Journal: J Mol Med (Berl) Date: 2019-12-17 Impact factor: 4.599
Authors: Rachel J Gibson; Dorothy M K Keefe; Rajesh V Lalla; Emma Bateman; Nicole Blijlevens; Margot Fijlstra; Emily E King; Andrea M Stringer; Walter J F M van der Velden; Roger Yazbeck; Sharon Elad; Joanne M Bowen Journal: Support Care Cancer Date: 2012-11-10 Impact factor: 3.603
Authors: Joanne M Bowen; Bronwen J Mayo; Erin Plews; Emma Bateman; Andrea M Stringer; Frances M Boyle; John W Finnie; Dorothy M K Keefe Journal: Cancer Biol Ther Date: 2012-08-16 Impact factor: 4.742
Authors: Hannah R Wardill; Joanne M Bowen; Noor Al-Dasooqi; Masooma Sultani; Emma Bateman; Romany Stansborough; Joseph Shirren; Rachel J Gibson Journal: Cancer Biol Ther Date: 2013-12-06 Impact factor: 4.742
Authors: R C P Lima-Júnior; H C Freitas; D V T Wong; C W S Wanderley; L G Nunes; L L Leite; S P Miranda; M H L P Souza; G A C Brito; P J C Magalhães; M M Teixeira; F Q Cunha; R A Ribeiro Journal: Br J Pharmacol Date: 2014-05 Impact factor: 8.739
Authors: Andrea M Stringer; Noor Al-Dasooqi; Joanne M Bowen; Thean H Tan; Maryam Radzuan; Richard M Logan; Bronwen Mayo; Dorothy M K Keefe; Rachel J Gibson Journal: Support Care Cancer Date: 2013-02-10 Impact factor: 3.603